Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
2.580
-0.500 (-16.23%)
At close: Apr 1, 2025, 4:00 PM
2.985
+0.405 (15.71%)
After-hours: Apr 1, 2025, 4:39 PM EDT
Clene Revenue
In the year 2024, Clene had annual revenue of $342.00K, down -47.71%. Clene had revenue of $91.00K in the quarter ending December 31, 2024, a decrease of -46.47%.
Revenue (ttm)
$342.00K
Revenue Growth
-47.71%
P/S Ratio
62.63
Revenue / Employee
$4,024
Employees
85
Market Cap
22.15M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 680.99B |
Costco Wholesale | 264.09B |
PepsiCo | 91.85B |
The Procter & Gamble Company | 84.35B |
Unilever | 62.91B |
Anheuser-Busch InBev | 59.77B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 37.88B |
CLNN News
- 8 hours ago - Clene to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 8 days ago - Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 20 days ago - Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment - GlobeNewsWire
- 26 days ago - Clene to Present at the 37TH Annual Roth Conference - GlobeNewsWire
- 4 weeks ago - Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11 - Accesswire
- 5 weeks ago - Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction - GlobeNewsWire
- 4 months ago - FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS - GlobeNewsWire
- 6 months ago - Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules - GlobeNewsWire